From CDC: 5,500 reported breakthrough infections of vaccinated people resulting in hospitalization or death from a population of 159 million fully vaccinated people.
https://www.cdc.gov/vaccines/covid-1...ugh-cases.html
"No free man shall ever be debarred the use of arms." - Thomas Jefferson, Virginia Constitution, Draft 1, 1776
Moderna
https://clinicaltrials.gov/ct2/show/NCT04470427
PfizerActual Enrollment : 30420 participants
Actual Study Start Date : July 27, 2020
Estimated Primary Completion Date : October 27, 2022
Estimated Study Completion Date : October 27, 2022
https://clinicaltrials.gov/ct2/show/NCT04368728
Estimated Enrollment : 43998 participants
Actual Study Start Date : April 29, 2020
Estimated Primary Completion Date : November 2, 2021
Estimated Study Completion Date : May 2, 2023
So using this data we have a .003% of vaccinated people being hospitalized/dying from COVID. I realize this will change as time goes on and I also realize that it doesn't account for the infections of people who never knew they were infected, but the vaccines look pretty damned effective.
Last edited by Spartan1980; 07-18-2021 at 11:35 AM.
Just curious.
Is anyone here arguing that the vaccine is ineffective at reducing the number (and/or severity) of COVID cases?
(edit: clarification.)
Last edited by David S.; 07-18-2021 at 02:24 PM.
David S.
IIRC, way before Covid, I read articles about the hypothesis that mRNA vaccines would lead to much more long-lasting immunity than traditional vaccines. Looks good so far.
But if a new strain bypasses the immunity of the current vaccination, I can't imagine we would have time to get a booster out without extensive genetic testing on the virus globally and a plan to produce and distribute the booster at transwarp speed.
Am I being too pessimistic?
REPETITION CREATES BELIEF
REPETITION BUILDS THE SEPARATE WORLDS WE LIVE AND DIE IN
NO EXCEPTIONS
I'm guessing, that a booster is, like anything, part of a solution that overlaps with other solutions. If some really new and nasty variation breaks out, you try it slow it down with social distancing, partial shutdowns, and quarantines to buy time for to research what the booster needs to contain. If I had any sway at an R&D branch of a pharmaceutical company, I'd have my people working on stuff for any variant that rears its head to reduce the lead time for the one that ends up becoming problematic. I imagine there are a few universities doing the same thing.
At least the we have better experience with the mass manufacture and distribution of vaccines now compared to a year ago.
Yeah, and mRNA vaccines can be developed and produced faster than then the alternatives. But given the problems with vaccine acceptance, it's hard for me seeing boosters doing enough soon enough to affect the strain that evades the current vaccines as far as transmission goes.
Would it be prudent to start boosting against Delta anyway, on the assumption that the strain that does require a booster for sure will be more similar to Delta than the original strain?
I'm guessing the answer to that question is "no," since I pulled that reasoning out of my posterior.
REPETITION CREATES BELIEF
REPETITION BUILDS THE SEPARATE WORLDS WE LIVE AND DIE IN
NO EXCEPTIONS